The Role of Plasminogen Activator Inhibitor-1 in the Metabolic Syndrome and Its Regulation
Abstract
<p>Obesity is a major risk factor for cardiovascular disease (CVD). Lipid abnormalities, hypertension, impaired glucose tolerance or diabetes, are cardiovascular risk factors that are frequently present in patients with obesity. Haemostatic and fibrinolytic disturbances are also considered to be important risk factors for CVD hence, a potential link between CVD, obesity and the metabolic syndrome arises. Regulation of the fibrinolytic...
Paper Details
Title
The Role of Plasminogen Activator Inhibitor-1 in the Metabolic Syndrome and Its Regulation
Published Date
Aug 3, 2014
Journal
Volume
3
Issue
6
Pages
36 - 36
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History